Saturday, July 5, 2025

Creating liberating content

If you or someone you know experiences any of these

Ayurveda, the ancient Indian system of medicine, isn’t just for

NEW DELHI: India on Friday proposed imposing of retaliatory duties

Related News

Retail inflation is expected to remain comfortably within the Reserve Bank of India’s (RBI) projections for the first quarter of FY26, supported by a favourable base effect and continued deflation

If you or someone you know experiences any of these symptoms—particularly in the setting of risk factors like diabetes, high blood pressure, a family history of kidney disease, or long-term

Ayurveda, the ancient Indian system of medicine, isn’t just for adults. Almost everyone in the world right now is stressed, and children are no different. The new age kids of

NEW DELHI: India on Friday proposed imposing of retaliatory duties under WTO norms against the US tariffs on imports of auto parts in the name of safeguard measures.“The proposed suspension

NEW DELHI: Fair trade regulator CCI has directed Aditya Birla firm UltraTech, which now owns south-based cement firm India Cements, along with two other makers and their executives to submit

Gold rose – putting it on track for a 2% weekly gain – as President Donald Trump said some US trading partners would face tariffs from Aug 1. Bullion rose

Trending News

Retail inflation is expected to remain comfortably within the Reserve Bank of India’s (RBI) projections for the first quarter of FY26, supported by a favourable base effect and continued deflation

NEW DELHI: Fair trade regulator CCI has directed Aditya Birla firm UltraTech, which now owns south-based cement firm India Cements, along with two other makers and their executives to submit

CHENNAI: A weak rupee was among the reasons that made foreign currency deposits attractive for NRIs. The net inflow under foreign currency non-resident (B) accounts increased by 11% to $7.1

The free trade agreement between India and the European Free Trade Association (EFTA) is likely to be implemented in the next couple of months, Commerce and Industry Minister Piyush Goyal

India’s Competition watchdog, the Competition Commission of India (CCI) has directed UltraTech Cement — which now controls India Cements — along with Dalmia Bharat and Shree Digvijay Cement, to furnish

Gold rate today: Gold prices declined sharply by Rs 600 to Rs 99,020 per 10 grams in Delhi on Friday, driven by fresh selling from stockists and a stronger US

Top stocks to buy: Stock recommendations for the week starting March 24, 2025

Word Count: 630 | Estimated Reading Time: 4 minutes


Top stocks to buy: Stock recommendations for the week starting March 24, 2025
Top stocks to buy (AI image)

Stock market recommendations: According to Motilal Oswal Financial Services Ltd, the top stock picks for the week (starting March 24, 2025) are Amber Enterprises and Kirloskar Oil. Let’s take a look:

Stock NameCMP (Rs)Target (Rs)Upside (%)
Amber Enterprises6888780013%
Kirloskar Oil748115054%

Amber Enterprises
Amber Enterprises is a leading Indian contract manufacturer for RAC and components, with growing capabilities in EMS. It benefits from strong client additions and industry demand tailwinds. Q3FY25 revenue grew 65% YoY, driven by RAC & electronics. Future growth is supported by capacity expansion. Amber is expanding its EMS segment, investing INR 6.5B in Ascent Circuit, and participating in India’s component PLI via a JV with Korea Circuit. Govt push for domestic manufacturing and potential incentives for electronics could benefit Amber. We estimate a revenue/EBITDA/PAT CAGR of 26%/33%/62% over FY24-27.
Kirloskar Oil
Powergen market demand over last 2 quarters was impacted by steep pricing increase & pre-buying ahead of CPCB 4+ implementation Demand is expected to stabilize from FY26, with ind. Vol. reaching 36-38k units in Q4, leading to improved volumes for KOEL. We expect KOEL to benefit from a shift towards mid to high kVA powergen segments, increased focus on new industrial areas, improved distribution touchpoints and better B2C profitability in the coming years. We estimate KOEL to achieve 17%/19% CAGR in EBITDA/PAT, with strong growth in B2B & 10% CAGR in B2C segment & EBITDA margin expanding to 13% by FY26. Stock is trading at significant discount (23x/19x FY25/26 earnings) compared to market leaders, with CMP reflecting unwarranted pessimism about growth and margins.
Disclaimer: The opinions, analyses and recommendations expressed herein are those of brokerage and do not reflect the views of The Times of India. Always consult with a qualified investment advisor or financial planner before making any investment decisions.





Source link

Sign In

Welcome ! Log into Your Account